BAG3 and familial pancreatic carcinoma: Forfurther looking at other eligible tumors, other than pancreatic cancer, for anti‐BAG3‐ based therapeutics, a database containing both gene expression data and patients' outcome26 was used to find out possible correlations between bag3 levels in the tumor specimens and patient's overall outcome.